Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Commercial Insight: Pain Market Overview' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Anticonvulsants Market to 2016 Cost Advantage and Dosage Convenience Provided by Generic Anticonvulsants Will Limit Commercial Opportunities for Novel Therapies |
Jan 2011 | £2,215 | 100% |
| Neuropathic Pain Market Forecast | Jan 2011 | £9,615 | 99% |
| The Global Pain Therapeutics Market 4th Edition: Market Trends & R&D Insights |
Nov 2010 | £1,105 | 94% |
| Pipeline Insight: Breakthrough Pain Fast-acting players will capture majority market share |
Nov 2006 | £7,210 | 93% |
| Pipeline Insight: Osteoarthritis The Wait for a DMOAD Continues |
Nov 2006 | £7,210 | 90% |
| Commercial Insight: Osteoarthritis Market sees steady growth |
Dec 2006 | £8,365 | 78% |
| Stakeholder Opinions: Bone Metastases Impending Patent Expiries May Help Make or Break Newer Agents |
Mar 2008 | £2,400 | 75% |
| Virtual Reality (VR) in Healthcare in the U.S. | Feb 2011 | £2,215 | 71% |
| The World Market for Gynaecology 2007-2017 |
Sep 2007 | £3,200 | 71% |
| Advances in Neurostimulators | Apr 2010 | £4,110 | 69% |
| GPCRs in Drug Discovery Efforts to De-Orphanize Novel Gpcr Targets Are Increasing |
Nov 2011 | £2,215 | 68% |
| Commercial Insight: Osteoporosis Market players maximize revenue growth before the next challenging phase |
Jul 2010 | £9,615 | 68% |
| Pipeline Insight: Epilepsy Past successes hard to emulate in highly genericized market |
May 2010 | £7,210 | 66% |
| Acrux Limited - Financial and Strategic Analysis Review | Apr 2009 | £79 | 64% |
| Next Frontier of Healthcare Payer Business Intelligence Strategies, The | Jan 2008 | £1,580 | 64% |
| Top 10 Drug Delivery Technologies Market | Feb 2011 | £2,940 | 63% |
| World Market for Sexual Disorders, 2005-2012, The Traversing New Frontiers in Sexual Chemistry |
Jan 2006 | £795 | 62% |
| Smith & Nephew Plc Product Pipeline Analysis | Jan 2009 | £475 | 61% |
| New Drug Futures 2009 | Jan 2012 | £1,995 | 61% |
| Medical Imaging Markets: Image-Guided Surgery | Aug 2011 | £2,215 | 59% |
| Leading Drug Delivery Companies and Technologies Competitive landscape, company profiles and technological developments |
Jun 2008 | £2,425 | 58% |
| Antiageing and Life Enhancement Pharmacotherapeutics | Jan 2006 | £795 | 58% |
| New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency | May 2009 | £3,605 | 56% |
| Weight Control Products | Feb 2011 | £2,845 | 52% |
| Top 10 Medical Device Technology 2009 - 2014 |
Sep 2009 | £2,940 | 51% |
| United States Diagnostic Imaging Market Outlook to 2017 Ultrasound Systems, MRI Systems, Computed Tomography Systems, Nuclear Imaging Equipment, X-Ray Systems, Mammography Equipment and Others |
Sep 2011 | £1,580 | 51% |
| Global Biosimilars A return to optimism? |
Jan 2012 | £1,295 | 49% |
| Innovations in Protein Kinase Therapies: Company pipelines, therapeutic applications and market forecasts | May 2009 | £2,425 | 49% |
| Drug and Device Combination 2009 - 2014 |
Jul 2009 | £2,940 | 48% |
- Results 1 - 29 of 29
-
-
- 1
-
-
